Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 110.64K | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | 342.55k | Forward P/E | - | EPS next Y | - | 50D Avg Chg | - |
| Sales | 3.24M | PEG | - | EPS past 5Y | - | 200D Avg Chg | - |
| Dividend | N/A | Price/Book | 0.00 | EPS next 5Y | - | 52W High Chg | - |
| Recommedations | - | Quick Ratio | 0.48 | Shares Outstanding | - | 52W Low Chg | - |
| Insider Own | - | ROA | 4.05% | Shares Float | - | Beta | -39.01 |
| Inst Own | - | ROE | 7.78% | Shares Shorted/Prior | -/- | Price | 0.00010 |
| Gross Margin | 88.80% | Profit Margin | 10.58% | Avg. Volume | 299 | Target Price | - |
| Oper. Margin | -8.89% | Earnings Date | - | Volume | 5,000 | Change | 0.00% |
About GENEX PHARMACEUTICALS INC
Genex Pharmaceutical, Inc. produces and distributes Reconstituted Bone Xenograft (RBX) in the People's Republic of China. The RBX is a medical device that accelerates bone healing. The company distributes its medical devices to approximately 500 hospitals, as well as to other medical device customers. Genex Pharmaceutical, Inc. was founded in 2003 and is headquartered in Tianjin City, the People's Republic of China.